DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Noxafil (Posaconazole) - Adverse Event Reports - Hospitalization - Somnolence

 



Index of reports > Cases resulting in hospitalization (22) > Cases with Somnolence (3)

Below is the selection of adverse event reports related to Noxafil (Posaconazole) that includes cases resulting in hospitalization where reactions include somnolence.

Adverse event in 9 year old female receiving Noxafil (Posaconazole)

Reported by a physician from France on 2007-10-01

Patient: 9 year old female

Adverse reactions / side effects: Hyponatraemia, Coma, Depressed Level of Consciousness, Metabolic Disorder, Somnolence, Convulsion

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Cytarabine
    Dosage: ; inth
    Indication: Drug USE FOR Unknown Indication
    Start date: 2007-06-10
    End date: 2007-06-10

Kidrolase (Asparaginase)
    Dosage: 25000 iu; once; im
    Indication: Chemotherapy
    Start date: 2007-06-16
    End date: 2007-06-16

Methotrexate
    Dosage: 120 mcg; once; iv
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-06-15
    End date: 2007-06-15

Noxafil
    Indication: Fungal Infection
    Start date: 2007-06-01
    End date: 2007-07-02

Oncovin
    Dosage: 1800 mcg; qd; iv
    Indication: Chemotherapy
    Start date: 2007-06-15
    End date: 2007-06-16

Other drugs received by patient: Nubain



Adverse event in female receiving Noxafil (Posaconazole)

Reported by a health professional (non-physician/pharmacist) from Germany on 2007-06-19

Patient: female, weighing 48.1 kg (105.8 pounds)

Adverse reactions / side effects: Blood Bilirubin Increased, Hypovolaemic Shock, Pruritus, Disseminated Intravascular Coagulation, Prothrombin Time Prolonged, Pyrexia, B-Cell Lymphoma Stage III, Metabolic Disorder, Lung Injury, Bronchopulmonary Aspergillosis, Pneumonia, Blood Lactate Dehydrogenase Increased, General Physical Health Deterioration, Haemolysis, Fungal Infection, Aspartate Aminotransferase Increased, Disturbance in Attention, Colon Polypectomy, Hypersensitivity, Endometriosis, Osteoporosis, Chills, Salpingo-Oophorectomy, Somnolence, Polyneuropathy, Chest X-RAY Abnormal, Stem Cell Transplant, Capillary Leak Syndrome, Fatigue, Gamma-Glutamyltransferase Increased, Thyroidectomy, Liver Function Test Abnormal, Pleural Effusion, Antithrombin III Decreased, Thrombocytopenia, Haptoglobin Decreased, Haemoptysis, Laparoscopic Sterilisation, Rash, Varicose Vein, T-Cell Lymphoma Stage III, Osteoarthritis, Renal Failure, Diarrhoea, Cardiac Failure, Sepsis, Acute Hepatic Failure, Asthenia, Venous Stent Insertion, Infection

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Noxafil
    Dosage: unk, unk
    Start date: 2006-12-15
    End date: 2006-12-20

Tegretol
    Dosage: 200 mg/day
    Administration route: Oral

Other drugs received by patient: Cytarabine; Cytarabine; Rituximab; Cisplatin; Dexamethasone 0.5mg TAB; Carmustine; Etoposide; Melphalan; Liskantin; Kalinor Retard; Ambisome; Ambisome; Ambisome; Ambisome; Cancidas; Cancidas; Cancidas; Diflucan; Vfend; Acyclovir; Clexane; Palifermin; Palifermin; Tavanic



Adverse event in female receiving Noxafil (Posaconazole)

Reported by a physician from Germany on 2007-05-15

Patient: female, weighing 48.1 kg (105.8 pounds)

Adverse reactions / side effects: Blood Bilirubin Increased, Pruritus, Disseminated Intravascular Coagulation, Prothrombin Time Prolonged, Pyrexia, Chemotherapy, B-Cell Lymphoma Stage III, Metabolic Disorder, Bronchopulmonary Aspergillosis, Pneumonia, Blood Lactate Dehydrogenase Increased, General Physical Health Deterioration, Haemolysis, Fungal Infection, Aspartate Aminotransferase Increased, Disturbance in Attention, Colon Polypectomy, Hypersensitivity, Osteoporosis, Endometriosis, Chills, Salpingo-Oophorectomy, Somnolence, Chest X-RAY Abnormal, Polyneuropathy, Stem Cell Transplant, Fatigue, Gamma-Glutamyltransferase Increased, Thyroidectomy, Liver Function Test Abnormal, Pleural Effusion, Thrombocytopenia, Antithrombin III Decreased, Haptoglobin Decreased, Haemoptysis, Laparoscopic Sterilisation, Rash, Varicose Vein, T-Cell Lymphoma Stage III, Osteoarthritis, Diarrhoea, Sepsis, Acute Hepatic Failure, Asthenia, Venous Stent Insertion, Infection

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Noxafil
    Dosage: unk, unk
    Start date: 2006-12-15
    End date: 2006-12-20

Tegretol
    Dosage: 200 mg/day
    Administration route: Oral

Other drugs received by patient: Arac; Arac; Rituximab; Cisplatin; Dexamethasone 0.5mg TAB; Carmustine; Etoposide; Melphalan; Liskantin; Kalinor Retard; Ambisome; Ambisome; Ambisome; Ambisome; Cancidas; Cancidas; Cancidas; Diflucan; Vfend; Acyclovir; Clexane; Palifermin; Palifermin; Tavanic

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009